Incorporating sTILs Into PREDICT Substantially Improves the Model’s Ability to Distinguish High- and Low-Risk Patients with TNBC By Ogkologos - May 5, 2026 42 0 Facebook Twitter Google+ Pinterest WhatsApp Building the PREDICT_sTILs prognostication model Source RELATED ARTICLESMORE FROM AUTHOR FDA Grants Accelerated Approval to Sonrotoclax for Relapsed or Refractory Mantle Cell Lymphoma Ahead of key Competitiveness Council Meeting of European Research Ministers, ESMO calls for measures supporting a robust clinical research ecosystem in Europe that enables... EMA Recommends Granting a Marketing Authorisation for Generic Palbociclib MOST POPULAR Patients with Early Stage NSCLC Have a Higher TMB in Comparison... October 9, 2020 ESMO Congress 2024 Barcelona, Spain, 13-17 September September 3, 2024 The Pesticide Chemical Responsible For Mass Bee Die-Offs Is Killing Birds... August 20, 2020 A Summer Poem August 20, 2021 Load more HOT NEWS Eight Factors May Link Disparities in Cancer Death Rates and Income Epigenetic Changes Pinpointed as the Cause of Some GISTs Lisocabtagene Maraleucel in Relapsed or Refractory Large B-cell Lymphomas Combining Daratumumab with VRd Improves Outcomes in Patients with Transplant-Ineligible or...
